Form 4: Insmed Director Leo Lee Acquires 5,058 Restricted Stock Units
SEC Form 4 Filing
Director Leo Lee reports acquisition of 5,058 Restricted Stock Units (RSUs) in Insmed Inc.
Summary
- On May 15, 2025, Leo Lee, a director of Insmed Inc., acquired 5,058 Restricted Stock Units (RSUs).
- Each RSU represents a contingent right to receive one share of Insmed's common stock.
- The RSUs vest after one year, contingent upon the director remaining on the Board and attending at least 75% of Board meetings.
- Following the transaction, Lee beneficially owns 129,677 shares of Insmed common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, neither particularly positive nor negative. It simply reports a transaction.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company directors and officers.
Key Dates
| Date | Description |
|---|---|
| 05/15/2025 | Date of transaction: Leo Lee acquired 5,058 Restricted Stock Units. |
| 05/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Insmed, Director, Leo Lee, RSU, Restricted Stock Units, Beneficial Ownership, Form 4, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.